Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison.

Pulm Ther · 2026 · PMC12992723 · PMID 41004068

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

METREO did not reach statistical significance for the primary endpoint, and no improvements in patient-reported outcome measures (SGRQ) or COPD assessment test (CAT) scores were observed.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.